UA80570U - Method for treating purulonecrotic processes in diabetes mellitus - Google Patents

Method for treating purulonecrotic processes in diabetes mellitus

Info

Publication number
UA80570U
UA80570U UAU201211631U UAU201211631U UA80570U UA 80570 U UA80570 U UA 80570U UA U201211631 U UAU201211631 U UA U201211631U UA U201211631 U UAU201211631 U UA U201211631U UA 80570 U UA80570 U UA 80570U
Authority
UA
Ukraine
Prior art keywords
purulonecrotic
treating
processes
diabetes mellitus
fibrinolysin
Prior art date
Application number
UAU201211631U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Александр Владимирович Пиптюк
Святослав Богданович Телемуха
Владимир Александрович Пиптюк
Original Assignee
Александр Владимирович Пиптюк
Святослав Богданович Телемуха
Владимир Александрович Пиптюк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Александр Владимирович Пиптюк, Святослав Богданович Телемуха, Владимир Александрович Пиптюк filed Critical Александр Владимирович Пиптюк
Priority to UAU201211631U priority Critical patent/UA80570U/en
Publication of UA80570U publication Critical patent/UA80570U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A method for treating purulonecrotic processes in diabetes mellitus consists in cannulation of the inferior epigastric artery followed by intra-arterial administration of the drugs. Furthermore, fibrinolysin and heparin are administered regionally at a dose of 2,000 U and 1,000 U, correspondingly, for 170-180 minutes once a day for 5-7 days.
UAU201211631U 2012-10-08 2012-10-08 Method for treating purulonecrotic processes in diabetes mellitus UA80570U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201211631U UA80570U (en) 2012-10-08 2012-10-08 Method for treating purulonecrotic processes in diabetes mellitus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201211631U UA80570U (en) 2012-10-08 2012-10-08 Method for treating purulonecrotic processes in diabetes mellitus

Publications (1)

Publication Number Publication Date
UA80570U true UA80570U (en) 2013-06-10

Family

ID=51949095

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201211631U UA80570U (en) 2012-10-08 2012-10-08 Method for treating purulonecrotic processes in diabetes mellitus

Country Status (1)

Country Link
UA (1) UA80570U (en)

Similar Documents

Publication Publication Date Title
AU2018201942B2 (en) Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
MX2015008011A (en) Supplements and monitoring systems for dosing of the supplements.
MY179194A (en) Process for preparing therapeutic nanoparticles
MY181539A (en) Composition for treating diabetes comprising long-acting insulin analogue conjugate and long-acting insulinotropic peptide conjugate
MX2016008013A (en) Antibody drug conjugates (adcs) with kinesin spindel protein (ksp).
GEP201706719B (en) Pirfenidone treatment for patients with atypical liver function
WO2013166449A3 (en) Methods for the treatment of diabetic retinopathy and other ophthalmic diseases
EA033067B1 (en) Method for treating metabolic disorders in a patient having a contraindication for a biguanide compound
WO2013033657A3 (en) CaMKII, IP3R, CALCINEURIN, P38 AND MK2/3 INHIBITORS TO TREAT METABOLIC DISTURBANCES OF OBESITY
UA105191C2 (en) Treatment with pirfenidone of patients with abnormal liver function
IN2014CN02688A (en)
WO2014153385A3 (en) Methods of treating metabolic disorders
MX2016000220A (en) Regulation of glucose metabolism using anti-cgrp antibodies.
MX339243B (en) Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof.
WO2014066400A3 (en) Methods for the effective treatment of metastatic cancer
MX366309B (en) Pharmaceutical composition for treating inflammation and pain.
UA80570U (en) Method for treating purulonecrotic processes in diabetes mellitus
UA109944U (en) PHARMACEUTICAL COMPOSITION TO REDUCE THE N-OXIDE OF TRIMETHYLAMINE LEVEL
WO2013090319A3 (en) Treatment of type i and type ii diabetes
RU2012123182A (en) METHOD FOR CORRECTION OF MENTAL STATE OF PATIENTS AND ANTIOXIDANT STATUS IN ORGANIC DISORDER OF PERSONALITY
MX2015004940A (en) Treatment of depression and ptsd.
UA64067U (en) Method for treating patients with stevens-johnson syndrome
UA74770U (en) method for treating patients with chronic hepatobiliary pathology on the background of enhanced fatigue syndrome
UA84191U (en) Method for treating patients with non-alcoholic steatohepatitis in setting of diabetes mellitus type 2
UA54839U (en) Method for treating psoriasis